Cardinal Health Secures $4 Billion Revolving Credit Facility, Consolidates Financing Structure
The healthcare services giant replaces three existing facilities with a single five-year agreement led by Wells Fargo, extending financial flexibility through 2031.
New Credit Agreement Details
Cardinal Health, Inc. (CAH) disclosed on August 11 that it has entered into a new $4 billion unsecured revolving credit facility, significantly restructuring its corporate financing arrangements. The Credit Agreement, dated August 7, 2026, was executed with Wells Fargo Bank, National Association serving as Administrative Agent, alongside a syndicate including BofA Securities, Goldman Sachs Bank USA, and JPMorgan Chase Bank as Joint Lead Arrangers and Joint Bookrunners (8-K filing, 2026-08-11).
The new facility provides "access to $4.0 billion of revolving credit through August 7, 2031" and includes provisions allowing the company to extend the termination date "by up to two years" subject to specified conditions (8-K filing, 2026-08-11). The agreement is designated for "general corporate purposes," offering the $56 billion market cap healthcare distributor enhanced financial flexibility.
Consolidation of Existing Facilities
The new credit agreement replaces three separate financing arrangements that collectively provided approximately $4 billion in capacity. Cardinal Health terminated its $2 billion Five-Year Credit Agreement dated February 27, 2023, its $1 billion 364-Day Credit Agreement from October 7, 2025, and a $1 billion receivables sale facility program (8-K filing, 2026-08-11).
Notably, the company "incurred no penalties" as a result of these terminations, suggesting the consolidation was executed on favorable terms (8-K filing, 2026-08-11). The receivables facility involved "Cardinal Health Funding, LLC" and "Cardinal Health 23 Funding, LLC" as financing subsidiaries, along with a performance guaranty structure that has now been unwound.
Financial Covenants and Terms
The Credit Agreement contains what the filing describes as "customary representations and affirmative and negative covenants" (8-K filing, 2026-08-11). The principal financial covenant requires Cardinal Health to maintain a "Consolidated Net Leverage Ratio" of "no greater than 4.00 to 1.00" as of the last day of any fiscal quarter (8-K filing, 2026-08-11).
The agreement also includes standard events of default provisions, encompassing "non-payment of principal or interest and breaches of covenants" (8-K filing, 2026-08-11). The document notes that participating financial institutions "have performed, and may in the future perform, various commercial banking, investment banking and other financial advisory services" for Cardinal Health, receiving "customary fees and expenses" (8-K filing, 2026-08-11).
Timing and Context
The filing was signed by Aaron E. Alt, Chief Financial Officer, on August 11, 2026 (8-K filing, 2026-08-11). According to MarginX data, Cardinal Health is scheduled to report its fourth quarter 2026 results on the same date as this filing. Recent MarginX data also shows insider award activity, with CFO Alt receiving 58,738 shares.
The Credit Agreement includes multiple tranches with CUSIP numbers 14149MAQ7 for the deal and 14149MAR5 for the revolver component, and involves documentation agents including Barclays Bank plc, Deutsche Bank AG New York Branch, HSBC Bank USA, PNC Bank, and The Bank of Nova Scotia (8-K filing, 2026-08-11).
This article was generated by MarginX from the 8-K filing on 2026-08-11. It is not investment advice.